Pathogenic Agents of Alzheimer’s Disease and Their Corresponding Pharmacotherapeutic Treatment Hypotheses

Pathogenic Agents of Alzheimer’s Disease and Their Corresponding Pharmacotherapeutic Treatment Hypotheses

by | Apr 16, 2021 | Alzheimer's Disease, I. Issues, II. Roles, Medical Officers, Physical Therapy / Medicine and Rehabilitation, Prescribers

Alzheimer’s Disease (AD), the most common cause of dementia, is a progressive and fatal neurodegenerative disorder that primarily affects older adults. Though the definitive etiology of the disease is still to be uncovered, several characteristic features of the...
The Etiology of Alzheimer’s Disease Reveals Potential Applications for Precision-Based Gene Therapy Utilizing the CRISPR/Cas9 Protocol To Counter Mechanisms of Pathogenesis

The Etiology of Alzheimer’s Disease Reveals Potential Applications for Precision-Based Gene Therapy Utilizing the CRISPR/Cas9 Protocol To Counter Mechanisms of Pathogenesis

by | Apr 9, 2021 | Alzheimer's Disease, I. Issues, II. Roles, IV. Others, Medical Officers

The CRISPR-Cas9 genome-editing system is a part of the adaptive immune system in archaea and bacteria to defend against invasive nucleic acids from phages and plasmids. The guide RNA (sgRNA) of the system recognizes its target sequence in the genome, and the Cas9...